Fibroblast growth factor 2 inhibits up-regulation of bone morphogenic proteins and their receptors during osteoblastic differentiation of human mesenchymal stem cells

Biochemical and Biophysical Research Communications

Volumn 427, Issue 4, 2012, Pages 737-742

  Biver, Emmanuel ^a,b,c   Soubrier, Anne Sophie ^a,b   Thouverey, Cyril ^c   Cortet, Bernard ^a,b   Broux, Odile ^a   Caverzasio, Joseph ^c   Hardouin, Pierre ^a  

^a UNIV LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Bone morphogenic proteins; Fibroblast growth factor 2; Human mesenchymal stem cells

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; FIBROBLAST GROWTH FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CELL DIFFERENTIATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MESENCHYMAL STEM CELL; NORMAL HUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLAST GROWTH FACTOR 2; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; UP-REGULATION;

EID: 84868206979     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.09.129     Document Type: Article

References (42)

1. Bianco P., Riminucci M., Gronthos S., Robey P.G. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001, 19:180-192.
2. Jaiswal N., Haynesworth S.E., Caplan A.I., Bruder S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J. Cell. Biochem. 1997, 64:295-312.
3. Boerckel J.D., Kolambkar Y.M., Dupont K.M., Uhrig B.A., Phelps E.A., Stevens H.Y., Garcia A.J., Guldberg R.E. Effects of protein dose and delivery system on BMP-mediated bone regeneration. Biomaterials 2011, 32:5241-5251.
4. Guo X., Wang X.F. Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res. 2009, 19:71-88.
5. Li X., Cao X. BMP signaling and skeletogenesis. Ann. N.Y. Acad. Sci. 2006, 1068:26-40.
6. Biver E., Hardouin P., Caverzasio J. The " bone morphogenic proteins" pathways in bone and joint diseases: translational perspectives from physiopathology to therapeutic targets. Cytokine Growth Factor Rev. 2012, 10.1016/j.cytogfr.2012.06.003.
7. Kang Q., Song W.X., Luo Q., Tang N., Luo J., Luo X., Chen J., Bi Y., He B.C., Park J.K., Jiang W., Tang Y., Huang J., Su Y., Zhu G.H., He Y., Yin H., Hu Z., Wang Y., Chen L., Zuo G.W., Pan X., Shen J., Vokes T., Reid R.R., Haydon R.C., Luu H.H., He T.C. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev. 2009, 18:545-559.
8. Huang H., Song T.J., Li X., Hu L., He Q., Liu M., Lane M.D., Tang Q.Q. BMP signaling pathway is required for commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc. Natl. Acad. Sci. USA 2009, 106:12670-12675.
9. Yoon B.S., Lyons K.M. Multiple functions of BMPs in chondrogenesis. J. Cell. Biochem. 2004, 93:93-103.
10. Lissenberg-Thunnissen S.N., de Gorter D.J., Sier C.F., Schipper I.B. Use and efficacy of bone morphogenetic proteins in fracture healing. Int. Orthop. 2011, 35:1271-1280.
11. Bragdon B., Moseychuk O., Saldanha S., King D., Julian J., Nohe A. Bone morphogenetic proteins: a critical review. Cell Signal. 2011, 23:609-620.
12. Miyazono K. Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. Bone 1999, 25:91-93.
13. Friedman M.S., Long M.W., Hankenson K.D. Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J. Cell. Biochem. 2006, 98:538-554.
14. Seib F.P., Franke M., Jing D., Werner C., Bornhauser M. Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells. Eur. J. Cell Biol. 2009, 88:257-271.
15. Lavery K., Swain P., Falb D., Alaoui-Ismaili M.H. BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. J. Biol. Chem. 2008, 283:20948-20958.
16. Abe E., Yamamoto M., Taguchi Y., Lecka-Czernik B., O'Brien C.A., Economides A.N., Stahl N., Jilka R.L., Manolagas S.C. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice. antagonism by noggin. J. Bone Miner. Res. 2000, 15:663-673.
17. Singhatanadgit W., Olsen I. Endogenous BMPR-IB signaling is required for early osteoblast differentiation of human bone cells. In Vitro Cell. Dev. Biol. Anim. 2011, 47:251-259.
18. Bolander M.E. Regulation of fracture repair by growth factors. Proc. Soc. Exp. Biol. Med. 1992, 200:165-170.
19. Krejci P., Prochazkova J., Bryja V., Kozubik A., Wilcox W.R. Molecular pathology of the fibroblast growth factor family. Hum. Mutat. 2009, 30:1245-1255.
20. Jackson R.A., Nurcombe V., Cool S.M. Coordinated fibroblast growth factor and heparan sulfate regulation of osteogenesis. Gene 2006, 379:79-91.
21. Huang Z., Nelson E.R., Smith R.L., Goodman S.B. The sequential expression profiles of growth factors from osteoprogenitors [correction of osteroprogenitors] to osteoblasts in vitro. Tissue Eng. 2007, 13:2311-2320.
22. Ornitz D.M., Marie P.J. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 2002, 16:1446-1465.
23. Du X., Xie Y., Xian C.J., Chen L. Role of FGFs/FGFRs in skeletal development and bone regeneration. J. Cell. Physiol. 2012, 227:3731-3743.
24. Fang M.A., Glackin C.A., Sadhu A., McDougall S. Transcriptional regulation of alpha 2(I) collagen gene expression by fibroblast growth factor-2 in MC3T3-E1 osteoblast-like cells. J. Cell. Biochem. 2001, 80:550-559.
25. Luong L.N., Ramaswamy J., Kohn D.H. Effects of osteogenic growth factors on bone marrow stromal cell differentiation in a mineral-based delivery system. Biomaterials 2012, 33:283-294.
26. Sapkota G., Alarcon C., Spagnoli F.M., Brivanlou A.H., Massague J. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol. Cell. 2007, 25:441-454.
27. Suzuki A., Guicheux J., Palmer G., Miura Y., Oiso Y., Bonjour J.P., Caverzasio J. Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation. Bone 2002, 30:91-98.
28. Ghali O., Chauveau C., Hardouin P., Broux O., Devedjian J.C. TNF-alpha's effects on proliferation and apoptosis in human mesenchymal stem cells depend on RUNX2 expression. J. Bone Miner. Res. 2010, 25:1616-1626.
29. Devescovi V., Leonardi E., Ciapetti G., Cenni E. Growth factors in bone repair. Chir. Organi Mov. 2008, 92:161-168.
30. Chen D., Ji X., Harris M.A., Feng J.Q., Karsenty G., Celeste A.J., Rosen V., Mundy G.R., Harris S.E. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J. Cell Biol. 1998, 142:295-305.
31. Zhao M., Harris S.E., Horn D., Geng Z., Nishimura R., Mundy G.R., Chen D. Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation. J. Cell Biol. 2002, 157:1049-1060.
32. Hughes-Fulford M., Li C.F. The role of FGF-2 and BMP-2 in regulation of gene induction, cell proliferation and mineralization. J. Orthop. Surg. Res. 2011, 6:8.
33. Phimphilai M., Zhao Z., Boules H., Roca H., Franceschi R.T. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. J. Bone Miner. Res. 2006, 21:637-646.
34. Ahn H.J., Lee W.J., Kwack K., Kwon Y.D. FGF2 stimulates the proliferation of human mesenchymal stem cells through the transient activation of JNK signaling. FEBS Lett. 2009, 583:2922-2926.
35. Guicheux J., Lemonnier J., Ghayor C., Suzuki A., Palmer G., Caverzasio J. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J. Bone Miner. Res. 2003, 18:2060-2068.
36. Marie P.J. Fibroblast growth factor signaling controlling bone formation: an update. Gene 2012, 498:1-4.
37. Sowa H., Kaji H., Yamaguchi T., Sugimoto T., Chihara K. Activations of ERK1/2 and JNK by transforming growth factor beta negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cells. J. Biol. Chem. 2002, 277:36024-36031.
38. Nakayama K., Tamura Y., Suzawa M., Harada S., Fukumoto S., Kato M., Miyazono K., Rodan G.A., Takeuchi Y., Fujita T. Receptor tyrosine kinases inhibit bone morphogenetic protein-Smad responsive promoter activity and differentiation of murine MC3T3-E1 osteoblast-like cells. J. Bone Miner. Res. 2003, 18:827-835.
39. Huang Y.F., Lin J.J., Lin C.H., Su Y., Hung S.C. C-Jun N-terminal kinase 1 negatively regulates osteoblastic differentiation induced by BMP2 via phosphorylation of Runx2 at Ser104. J. Bone Miner. Res. 2012, 27:1093-1105.
40. Fuentealba L.C., Eivers E., Ikeda A., Hurtado C., Kuroda H., Pera E.M., De Robertis E.M. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 2007, 131:980-993.
41. Ohba S., Yano F., Chung U.-i. Tissue engineering of bone and cartilage. IBMS BoneKEy 2009, 6:405-419.
42. Maegawa N., Kawamura K., Hirose M., Yajima H., Takakura Y., Ohgushi H. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2). J. Tissue Eng. Regen. Med. 2007, 1:306-313.